MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Nurse led intrajejunal levodopa pathway for a regional neurosciences centre

P. Duggan-Carter, J. Cosgrove, J. Alty (Leeds, United Kingdom)

Meeting: MDS Virtual Congress 2020

Abstract Number: 5

Keywords: Levodopa(L-dopa), Multidisciplinary Approach

Category: Allied Healthcare Professionals

Objective: To evaluate the impact of introducing a nurse led advanced therapy service for patients referred for levodopa/carbidopa intestinal gel (LCIG).

Background: Leeds Teaching Hospitals NHS Trust (LTHT) is a regional neurosciences centre and a specialist centre for people with Parkinson’s disease (PwPD) requiring advanced therapies in the Yorkshire and Humber region (population 5.4million). We identified that our existing service had prolonged waiting times and patient feedback suggested this was increasing anxiety about LCIG.

Method: Following a retrospective review of the LCIG journey for PwPD and their carers, a nurse-led LCIG pathway was developed and implemented in October 2019, after multi-disciplinary team (MDT) working involving Parkinson’s specialist nurses, neurologists, gastroenterologists, percutaneous endoscopic gastrostomy (PEG) specialist nurses and dieticians.

Results: Key outcomes from the nurse-led LCIG pathway include:
A new patient information leaflet outlining all aspects of the procedure including pre-assessment, PEG-Jejunal (PEG-J) insertion, hospital admission, drug initiation and titration.
Advanced therapy nurse-led clinics, with regular availability for nurse-led LCIG titrations
Standardised eight-week referral for outpatient PEG-J, to ensure timely and efficient insertion prior to drug initiation and titration.
Preliminary feedback suggests increased satisfaction from PwPD and carers. Initial data shows a quicker initial consultation after referral for LCIG (appointment in the nurse led advanced therapy clinic within four weeks compared to average of ten weeks before initial review previously) and quicker time to LCIG initiation and titration (fourteen weeks from referral compared to average of 28 weeks).

Conclusion: A MDT review of the LCIG service in our Trust has led to the creation of a nurse-led LCIG pathway. Provisional feedback suggests this is more efficient and increases patient and carer satisfaction.

To cite this abstract in AMA style:

P. Duggan-Carter, J. Cosgrove, J. Alty. Nurse led intrajejunal levodopa pathway for a regional neurosciences centre [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/nurse-led-intrajejunal-levodopa-pathway-for-a-regional-neurosciences-centre/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/nurse-led-intrajejunal-levodopa-pathway-for-a-regional-neurosciences-centre/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley